Pharmaceutical
| Sat 31 Jan 2026
Munich, Jan. 31 -- Adalvo Ltd and Win Medica SA have filed a patent application for a Fixed-dose Pharmaceutical Composition Comprising (2s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic Acid and (6r,12ar)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino{1',2:1,6]pyrido[3,4-b]indole-1,4-dio..